{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["ADMET.", "COVID-19", "MD simulation", "SARS-CoV-2", "medicinal plants", "molecular docking"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37861016", "DateCompleted": {"Year": "2024", "Month": "07", "Day": "22"}, "DateRevised": {"Year": "2024", "Month": "07", "Day": "22"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": ["10.2174/0115701638243222230920051050"], "Journal": {"ISSN": "1875-6220", "JournalIssue": {"Volume": "21", "Issue": "3", "PubDate": {"Year": "2024"}}, "Title": "Current drug discovery technologies", "ISOAbbreviation": "Curr Drug Discov Technol"}, "ArticleTitle": "<i>In Silico</i> Screening of Some Active Phytochemicals to Identify Promising Inhibitors Against SARS-CoV-2 Targets.", "Pagination": {"StartPage": "73", "EndPage": "89", "MedlinePgn": "73-89"}, "Abstract": {"AbstractText": ["There are very few small-molecule drug candidates developed against SARS-CoV-2 that have been revealed since the epidemic began in November 2019. The typical medicinal chemistry discovery approach requires more than a decade of the year of painstaking research and development and a significant financial guarantee, which is not feasible in the challenge of the current epidemic.", "This current study proposes to find and identify the most effective and promising phytomolecules against SARS-CoV-2 in six essential proteins (3CL protease, Main protease, Papain- Like protease, N-protein RNA binding domain, RNA-dependent RNA polymerase, and Spike receptor binding domain target through <i>in silico</i> screening of 63 phytomolecules from six different Ayurveda medicinal plants.", "The phytomolecules and SARS-CoV-2 proteins were taken from public domain databases such as PubChem and RCSB Protein Data Bank. For <i>in silico</i> screening, the molecular interactions, binding energy, and ADMET properties were investigated.", "The structure-based molecular docking reveals some molecules' greater affinity towards the target than the co-crystal ligand. Our results show that tannic acid, cyanidin-3-rutinoside, zeaxanthin, and carbolactone are phytomolecules capable of inhibiting SARS-CoV-2 target proteins in the least energy conformations. Tannic acid had the least binding energy of -8.8 kcal/mol, which is better than the binding energy of its corresponding co-crystal ligand (-7.5 kcal/mol) against 3 CL protease. Also, it has shown the least binding energy of -9.9 kcal/mol with a more significant number of conventional hydrogen bond interactions against the RdRp target. Cyanidin-3-rutinoside showed binding energy values of -8.8 and -7.6 kcal/mol against Main protease and Papain-like protease, respectively. Zeaxanthin was the top candidate in the N protein RBD with a binding score of - 8.4 kcal/mol, which is slightly better when compared to a co-crystal ligand (-8.2 kcal/mol). In the spike, carbolactone was the suitable candidate with the binding energy of -7.2 kcal/mol and formed a conventional hydrogen bond and two hydrophobic interactions. The best binding affinity-scored phytomolecules were selected for the MD simulations studies.", "The present in silico screening study suggested that active phytomolecules from medicinal plants could inhibit SARS-CoV-2 targets. The elite docked compounds with drug-like properties have a harmless ADMET profile, which may help to develop promising COVID-19 inhibitors."], "CopyrightInformation": "Copyright\u00a9 Bentham Science Publishers; For any queries, please email at epub@benthamscience.net."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Chemistry Research Laboratory, MNR College of Pharmacy, Sangareddy, Gr. Hyderabad, 502 294, India."}], "LastName": "Alagarsamy", "ForeName": "V", "Initials": "V"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Chemistry Research Laboratory, MNR College of Pharmacy, Sangareddy, Gr. Hyderabad, 502 294, India."}], "LastName": "Solomon", "ForeName": "V Raja", "Initials": "VR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, BITS Pilani, Pilani Campus, Pilani, 333031, India."}], "LastName": "Murugesan", "ForeName": "S", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Chemistry Research Laboratory, MNR College of Pharmacy, Sangareddy, Gr. Hyderabad, 502 294, India."}], "LastName": "Sundar", "ForeName": "P Shyam", "Initials": "PS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, BITS Pilani, Pilani Campus, Pilani-333031, India."}], "LastName": "Muzaffar-Ur-Rehman", "ForeName": "M D", "Initials": "MD"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, BITS Pilani, Pilani Campus, Pilani, 333031, India."}], "LastName": "Chandu", "ForeName": "A", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Chemistry Research Laboratory, MNR College of Pharmacy, Sangareddy, Gr. Hyderabad, 502 294, India."}], "LastName": "Aishwarya", "ForeName": "A Dharshini", "Initials": "AD"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Chemistry Research Laboratory, MNR College of Pharmacy, Sangareddy, Gr. Hyderabad, 502 294, India."}], "LastName": "Narendhar", "ForeName": "B", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Chemistry Research Laboratory, MNR College of Pharmacy, Sangareddy, Gr. Hyderabad, 502 294, India."}], "LastName": "Sulthana", "ForeName": "M T", "Initials": "MT"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Chemistry Research Laboratory, MNR College of Pharmacy, Sangareddy - 502 294, Gr. Hyderabad, India."}], "LastName": "Ravikumar", "ForeName": "V", "Initials": "V"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United Arab Emirates", "MedlineTA": "Curr Drug Discov Technol", "NlmUniqueID": "101157212", "ISSNLinking": "1570-1638"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Phytochemicals"}, {"RegistryNumber": "0", "NameOfSubstance": "Antiviral Agents"}, {"RegistryNumber": "EC 3.4.22.28", "NameOfSubstance": "Coronavirus 3C Proteases"}, {"RegistryNumber": "EC 3.4.22.2", "NameOfSubstance": "Coronavirus Papain-Like Proteases"}, {"RegistryNumber": "EC 3.4.22.-", "NameOfSubstance": "3C-like proteinase, SARS-CoV-2"}], "MeshHeadingList": [{"QualifierName": ["drug effects"], "DescriptorName": "SARS-CoV-2"}, {"QualifierName": ["pharmacology", "chemistry"], "DescriptorName": "Phytochemicals"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": ["pharmacology", "chemistry"], "DescriptorName": "Antiviral Agents"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["antagonists & inhibitors", "metabolism", "chemistry"], "DescriptorName": "Coronavirus 3C Proteases"}, {"QualifierName": [], "DescriptorName": "COVID-19 Drug Treatment"}, {"QualifierName": [], "DescriptorName": "Computer Simulation"}, {"QualifierName": ["antagonists & inhibitors", "chemistry", "metabolism"], "DescriptorName": "Coronavirus Papain-Like Proteases"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Anand K.; Ziebuhr J.; Wadhwani P.; Mesters J.R.; Hilgenfeld R.; Coronavirus main proteinase (3CLpro) structure: Basis for design of anti-SARS drugs. Science 2003,300(5626),1763-1767", "ArticleIdList": ["10.1126/science.1085658", "12746549"]}, {"Citation": "Anderson R.M.; Heesterbeek H.; Klinkenberg D.; Hollingsworth T.D.; Hollingsworth, How will country-based mitigation measures influence the course of the COVID-19 epidemic? The Lancet 2020,395(10228),931-934"}, {"Citation": "Cinatl J.; Morgenstern B.; Bauer G.; Chandra P.; Rabenau H.; Doerr H.W.; Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. Lancet 2003,361(9374),2045-2046", "ArticleIdList": ["10.1016/S0140-6736(03)13615-X", "12814717"]}, {"Citation": "Gates B.; Responding to Covid-19 \u2014 A once-in-a-century pandemic? N Engl J Med 2020,382(18),1677-1679"}, {"Citation": "Gupta MK, Vemula S, Donde R, Gouda G, Behera L, Vadde R/. In-silico approaches to detect inhibitors of the human severe acute respiratory syndrome coronavirus envelope protein ion channel. J Biomol Struct Dyn 2020,39(7),2617-2627", "ArticleIdList": ["10.1080/07391102.2020.1751300"]}, {"Citation": "Pandey S.; Yadav B.; Pandey A.; Lessons from SARS-CoV-2 pandemic: Evolution, disease dynamics and future. Biology 2020,9(6),141", "ArticleIdList": ["10.3390/biology9060141", "32604825"]}, {"Citation": "Hilgenfeld R.; From SARS to MERS: Crystallographic studies on coronaviral proteases enable antiviral drug design. FEBS J 2014,281(18),4085-4096", "ArticleIdList": ["10.1111/febs.12936", "25039866"]}, {"Citation": "Hu T.; Two adjacent mutations on the dimer interface of SARS coronavirus 3C-like protease cause different conformational changes in crystal structure. Virology 2009,388(2),324-334"}, {"Citation": "Wu A.; Peng Y.; Huang B.; Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China. Cell Host Microbe 2020,27,325-328"}, {"Citation": "V\u2019kovski P.; Kratzel A.; Steiner S.; Stalder H.; Thiel V.; Coronavirus biology and replication: Implications for SARS-CoV-2. Nat Rev Microbiol 2021,19(3),155-170", "ArticleIdList": ["10.1038/s41579-020-00468-6", "33116300"]}, {"Citation": "Li G.; De Clercq E.; Therapeutic options for the 2019 novel coronavirus (2019-nCoV). Nat Rev Drug Discov 2020,19(3),149-150", "ArticleIdList": ["10.1038/d41573-020-00016-0", "32127666"]}, {"Citation": "Suwannarach N.; Kumla J.; Sujarit K.; Natural bioactive compounds from fungi as potential candidates for protease inhibitors and immunomodulators to apply for coronaviruses. Molecules 2020,25(8),1800", "ArticleIdList": ["10.3390/molecules25081800"]}, {"Citation": "Sen D.; Debnath P.; Debnath B.; Bhaumik S.; Debnath S.; Identification of potential inhibitors of SARS-CoV-2 main protease and spike receptor from 10 important spices through structure-based virtual screening and molecular dynamic study. J Biomol Struct Dyn 2022,40(2),941-962", "ArticleIdList": ["10.1080/07391102.2020.1819883", "32948116"]}, {"Citation": "Hu X.; Cai X.; Song X.; Possible SARS-coronavirus 2 inhibitor revealed by simulated molecular docking to viral main protease and host toll-like receptor. Future Virol 2020,15(6),359-368", "ArticleIdList": ["10.2217/fvl-2020-0099"]}, {"Citation": "Ibrahim M.A.A.; Abdelrahman A.H.M.; Hussien T.A.; In silico drug discovery of major metabolites from spices as SARS-CoV-2 main protease inhibitors. Comput Biol Med 2020,126,104046", "ArticleIdList": ["10.1016/j.compbiomed.2020.104046", "33065388"]}, {"Citation": "Ibrahim M.A.A.; Mohamed E.A.R.; Abdelrahman A.H.M.; Rutin and flavone analogs as prospective SARS-CoV-2 main protease inhibitors: In silico drug discovery study. J Mol Graph Model 2021,105,107904", "ArticleIdList": ["10.1016/j.jmgm.2021.107904", "33798836"]}, {"Citation": "Petricevich V.; Abarca-Vargas R.; Allamanda cathartica: A Review of the Phytochemistry, Pharmacology, Toxicology, and Biotechnology. Molecules 2019,24(7),1238", "ArticleIdList": ["10.3390/molecules24071238", "30934947"]}, {"Citation": "Hameed A.; Nawaz G.; Gulzar T.; Chemical composition, antioxidant activities and protein profiling of different parts of Allamanda cathartica. Nat Prod Res 2014,28(22),2066-2071", "ArticleIdList": ["10.1080/14786419.2014.923997", "24931146"]}, {"Citation": "Lam S.H.; Chen J.M.; Tsai S.F.; Lee S.S.; Chemical investigation on the root bark of Bombax malabarica. Fitoterapia 2019,139,104376", "ArticleIdList": ["10.1016/j.fitote.2019.104376", "31629048"]}, {"Citation": "Diab K.; El-Shenawy R.; Helmy N.; El-Toumy S.; Polyphenol content, antioxidant, cytotoxic, and genotoxic activities of bombax ceiba flowers in liver cancer cells Huh7. Asian Pac J Cancer Prev 2022,23(4),1345-1350", "ArticleIdList": ["10.31557/APJCP.2022.23.4.1345", "35485695"]}, {"Citation": "Asati N.; Yadava R.N.; Antibacterial activity of a triterpenoid saponin from the stems of Caesalpinia pulcherrima Linn. Nat Prod Res 2018,32(5),499-507", "ArticleIdList": ["10.1080/14786419.2017.1317772", "28423926"]}, {"Citation": "de Melo C.M.L.; da Cruz F.I.J.; de Sousa G.F.; Lignin isolated from Caesalpinia pulcherrima leaves has antioxidant, antifungal and immunostimulatory activities. Int J Biol Macromol 2020,162,1725-1733", "ArticleIdList": ["10.1016/j.ijbiomac.2020.08.003", "32777417"]}, {"Citation": "Moqbel S.A.A.; Xu K.; Chen Z.; Tectorigenin alleviates inflammation, apoptosis, and ossification in rat tendon-derived stem cells via modulating NF-Kappa B and MAPK pathways. Front Cell Dev Biol 2020,8,568894", "ArticleIdList": ["10.3389/fcell.2020.568894", "33195199"]}, {"Citation": "Li C.; Liu Y.; Lin F.; Zheng Y.; Huang P.; Characterization of the complete chloroplast genome sequences of six Dalbergia species and its comparative analysis in the subfamily of Papilionoideae (Fabaceae). PeerJ 2022,10,e13570", "ArticleIdList": ["10.7717/peerj.13570"]}, {"Citation": "Surana A.R.; Wagh R.D.; Phytochemical analysis and antidepressant activity of Ixora coccinea extracts in experimental models of depression in mice. Turk J Pharm Sci 2018,15(2),130-135", "ArticleIdList": ["10.4274/tjps.14622", "32454651"]}, {"Citation": "Ali Adnan M.S.; Al-Amin M.M.; Nasir U.M.M.; Analgesic, anti-inflammatory, and antipyretic effects of Ixora coccinea. J Basic Clin Physiol Pharmacol 2014", "ArticleIdList": ["10.1515/jbcpp-2013-0125"]}, {"Citation": "Abreu P.M.; Matthew S.; Gonz\u00e1lez T.; Isolation and identification of antioxidants from Pedilanthus tithymaloides. J Nat Med 2007,62(1),67-70", "ArticleIdList": ["10.1007/s11418-007-0186-z", "18404345"]}, {"Citation": "Vidotti G.J.; Zimmermann A.; Sarragiotto M.H.; Nakamura C.V.; Dias Filho B.P.; Antimicrobial and phytochemical studies on Pedilanthus tithymaloides. Fitoterapia 2006,77(1),43-46", "ArticleIdList": ["10.1016/j.fitote.2005.08.020", "16253438"]}, {"Citation": "Berman H.M.; Westbrook J.; Feng Z.; The protein data bank. Nucleic Acids Res 2000,28(1),235-242", "ArticleIdList": ["10.1093/nar/28.1.235", "10592235"]}, {"Citation": "RCSB Protein Data Bank: Powerful new tools for exploring 3D structures of biological macromolecules for basic and applied research and education in fundamental biology, biomedicine, biotechnology, bioengineering and energy sciences. Nucleic Acids Research 2021,49,D437-D451"}, {"Citation": "Garrett M.; AutoDock Version 42 - User Guide 2010,1-49", "ArticleIdList": ["10.1002/jcc.21334"]}, {"Citation": "Trott O; Olson AJ; AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading J Comput Chem 2009,31(2),NA", "ArticleIdList": ["10.1002/jcc.21334", "19499576"]}, {"Citation": "PerkinElmerInformaticshttp. Available from: www.cambridgesoft.com/Ensemble_for_Chemistry/details/Default.aspx?fid=16"}, {"Citation": "Nourhan M.; Olfat M.; Mohamed G.S.; El Sohaimy S.; Inhibition of COVID-19 RNA-dependent RNA polymerase by natural bioactive compounds: Molecular docking analysis. Egypt J Chem 2021,64(4),1989-2001", "ArticleIdList": ["10.21608/ejchem.2021.45739.2947"]}, {"Citation": "Li D.; Luan J.; Zhang L.; Molecular docking of potential SARS-CoV-2 papain-like protease inhibitors. Biochem Biophys Res Commun 2021,538,72-79", "ArticleIdList": ["10.1016/j.bbrc.2020.11.083", "33276953"]}, {"Citation": "Yadav R.; Chaudhary J.K.; Jain N.; Role of structural and non-structural proteins and therapeutic targets of SARS-CoV-2 for COVID-19. Cells 2021,10(4),821", "ArticleIdList": ["10.3390/cells10040821", "33917481"]}, {"Citation": "Lan J.; Ge J.; Yu J.; Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature 2020,581(7807),215-220", "ArticleIdList": ["10.1038/s41586-020-2180-5", "32225176"]}, {"Citation": "Kang S.; Yang M.; Hong Z.; Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites. Acta Pharm Sin B 2020,10(7),1228-1238", "ArticleIdList": ["10.1016/j.apsb.2020.04.009", "32363136"]}, {"Citation": "Client DS; Studio D; Discovery T; Client S; Introduction to the discovery studio visualizer. Available from: http://www.adrianomartinelli.it/Fondamenti/Tutorial_0.pdf"}, {"Citation": "Morris G.M.; Huey R.; Lindstrom W.; AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J Comput Chem 2009,30(16),2785-2791", "ArticleIdList": ["10.1002/jcc.21256", "19399780"]}, {"Citation": "Desmond Molecular Dynamics System 2020"}, {"Citation": "Maestro-Desmond Interoperability Tools 2020"}, {"Citation": "Jorgensen W.L.; Maxwell D.S.; Tirado-Rives J.; Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids. J Am Chem Soc 1996,118(45),11225-11236", "ArticleIdList": ["10.1021/ja9621760"]}, {"Citation": "Mark P.; Nilsson L.; Structure and dynamics of the TIP3P, SPC, and SPC/E water models at 298 K. J Phys Chem A 2001,105(43),9954-9960", "ArticleIdList": ["10.1021/jp003020w"]}, {"Citation": "Pires D.E.V.; Blundell T.L.; Ascher D.B.; pkCSM: Predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J Med Chem 2015,58(9),4066-4072", "ArticleIdList": ["10.1021/acs.jmedchem.5b00104"]}, {"Citation": "Kicker E.; Tittel G.; Schaller T.; Pferschy-Wenzig E.M.; Zatloukal K.; Bauer R.; SARS-CoV-2 neutralizing activity of polyphenols in a special green tea extract preparation. Phytomedicine 2022,98,153970", "ArticleIdList": ["10.1016/j.phymed.2022.153970", "35144138"]}, {"Citation": "Khalifa I.; Zhu W.; Mohammed H.H.H.; Dutta K.; Li C.; Tannins inhibit SARS\u2010CoV\u20102 through binding with catalytic dyad residues of 3CL pro: An in silico approach with 19 structural different hydrolysable tannins. J Food Biochem 2020,44(10),e13432", "ArticleIdList": ["10.1111/jfbc.13432", "32783247"]}, {"Citation": "Jing W.; Xiaolan C.; Yu C.; Feng Q.; Haifeng Y.; Pharmacological effects and mechanisms of tannic acid. Biomed Pharmacother 2022,154,113561", "ArticleIdList": ["10.1016/j.biopha.2022.113561", "36029537"]}, {"Citation": "Das A.; Pandita D.; Jain G.K.; Role of phytoconstituents in the management of COVID-19. Chem Biol Interact 2021,341,109449", "ArticleIdList": ["10.1016/j.cbi.2021.109449", "33798507"]}, {"Citation": "Wang S.C.; Chou I.W.; Hung M.C.; Natural tannins as anti-SARS-CoV-2 compounds. Int J Biol Sci 2022,18(12),4669-4676", "ArticleIdList": ["10.7150/ijbs.74676", "35874955"]}, {"Citation": "Espa\u00f1o E.; Kim J.; Lee K.; Kim J.K.; Phytochemicals for the treatment of COVID-19. J Microbiol 2021,59(11),959-977", "ArticleIdList": ["10.1007/s12275-021-1467-z", "34724178"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "1", "Day": "19"}, {"Year": "2023", "Month": "7", "Day": "29"}, {"Year": "2023", "Month": "8", "Day": "9"}, {"Year": "2024", "Month": "7", "Day": "22", "Hour": "6", "Minute": "42"}, {"Year": "2023", "Month": "10", "Day": "20", "Hour": "12", "Minute": "43"}, {"Year": "2023", "Month": "10", "Day": "20", "Hour": "6", "Minute": "35"}], "PublicationStatus": "ppublish", "ArticleIdList": ["37861016", "10.2174/0115701638243222230920051050", "CDDT-EPUB-134971"]}}], "PubmedBookArticle": []}